2m 2m 2m 2m 2m 2m 2m
ENVERIC BIOSCIE (ENVB)
NASDAQ
$2.00+$0.02 (+1.01%)
Price as of Jun 03, 2026 7:40 PM EDT- $8.5MMarket Cap
- -85.43%1-Year Change
- BiotechnologyIndustry
ENVERIC BIOSCIE (ENVB)
$2.00+$0.02 (+1.01%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | -106 -148.40% | 219 -94.09% | 3,708 N/A | N/A N/A | |
Cost of Revenue | 8.8M -8.91% | 9.6M -41.44% | 16.4M -40.00% | 27.4M -57.58% | |
Gross Profit | -8.8M -8.90% | -9.6M -41.43% | -16.4M -40.02% | -27.4M -57.58% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -2.8M -2.12% | -2.8M -60.82% | -7.3M -9.66% | -8.0M +67.64% | |
Depreciation and Amortization Expense | 42,182 -75.00% | 168,750 -0.002% | 168,754 +0.002% | 168,750 -73.77% | |
Total Operating Expenses | 14.6M -9.44% | 16.1M -36.42% | 25.3M -35.16% | 39.0M -54.16% | |
Operating Profit | -8.8M -8.91% | -9.6M -41.44% | -16.4M -40.00% | -27.4M -57.58% | |
Interest Income | 1,707 -92.10% | 21,620 -89.64% | 208,752 -93.99% | 3.5M N/A | |
Interest Expense | -106 N/A | N/A N/A | N/A N/A | -5,249 -49.12% | |
Interest Income and Expense and Net | 1,601 -92.59% | 21,620 -89.64% | 208,752 -93.98% | 3.5M +33,712.61% | |
Total Nonoperating Income and Expense | 2,461 -96.28% | 66,209 +108.13% | -814,379 -110.92% | 7.5M -8.96% | |
Income before Taxes | -8.8M -8.30% | -9.6M -44.59% | -17.3M -13.50% | -20.0M -64.63% | |
Income Taxes | N/A N/A | 8,930 -69.11% | 28,913 +101.95% | -1.5M -80.07% | |
Extraordinary Items | N/A N/A | N/A N/A | 6.0M 0.00% | 6.0M N/A | |
Net Income | -12.1M +26.70% | -9.6M -44.63% | -17.3M -6.39% | -18.5M -62.29% | |
Net Income from Continuing Operations Applicable to Common | -12.1M +26.70% | -9.6M -45.16% | -17.5M -7.14% | -18.8M -66.68% | |
Basic EPS and Net Income | -36.24 +90.34% | -19.04 +135.35% | -8.09 -37.77% | -13.00 +528.02% | |
Diluted EPS and Net Income | -36.24 +90.34% | -19.04 +135.35% | -8.09 -37.77% | -13.00 +528.02% | |
Basic Weighted Average Shares | 334,719 -33.44% | 502,900 -76.71% | 2.2M +49.31% | 1.4M -93.88% | |
Diluted Weighted Average Shares | 334,719 -33.44% | 502,900 -76.71% | 2.2M +49.31% | 1.4M -93.88% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 4.7M +108.72% | 2.2M -2.05% | 2.3M -87.09% | 17.7M +2.12% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 4.7M +108.72% | 2.2M -2.05% | 2.3M -87.09% | 17.7M +2.12% | |
Total Current Assets | 4.9M +80.53% | 2.7M -23.65% | 3.6M -80.57% | 18.4M +3.92% | |
Accumulated Depreciation | 675,552 +38.04% | 489,401 +36.81% | 357,711 +100.09% | 178,775 +553.78% | |
Property and Plant and Equipment and Net | 159,234 -47.92% | 305,777 -39.73% | 507,377 -25.11% | 677,485 +130.10% | |
Total Long-Term Assets | 159,234 -54.24% | 347,959 -51.56% | 718,309 -35.92% | 1.1M -87.52% | |
Total Assets | 5.1M +65.32% | 3.1M -28.31% | 4.3M -78.01% | 19.6M -26.82% | |
Income Taxes Payable | N/A N/A | 261,100 -52.14% | 545,602 -68.01% | 1.7M N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 918,400 -38.35% | 1.5M -36.43% | 2.3M -41.35% | 4.0M +91.79% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | N/A N/A | N/A N/A | 3.6M -74.98% | 14.4M +517.62% | |
Total Liabilities | 918,400 -38.35% | 1.5M -36.43% | 2.3M -41.35% | 4.0M -9.45% | |
Retained Earnings | -114.8M +8.27% | -106.1M +9.92% | -96.5M +21.83% | -79.2M +30.41% | |
Total Stockholders Equity | N/A N/A | N/A N/A | 2.0M -86.67% | 14.7M -34.22% | |
Total Shares Outstanding | 1.1M +56.57% | 678,002 -75.25% | 2.7M +31.81% | 2.1M -93.62% | |
Cash Flow | |||||
Cash from Operating Activities | -8.1M +5.38% | -7.7M -45.18% | -14.1M -17.80% | -17.1M +49.65% | |
Capital Expenditures | N/A N/A | N/A N/A | 5,180 -99.11% | 584,165 +207.91% | |
Cash from Investing Activities | N/A N/A | N/A N/A | 11,667 +102.00% | -584,165 -126.67% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 10.6M +37.86% | 7.7M +671.33% | -1.3M -107.39% | 18.2M -26.99% | |
Financials Ratio | |||||
Gross Margin | 8,277,881.13% +288.21% | -4,398,194.98% +891.72% | -443,493.31% N/A | N/A N/A | |
Operating Margin | 8,277,781.13% +288.20% | -4,398,294.98% +891.52% | -443,593.31% N/A | N/A N/A | |
Return on Assets | -296.67% +14.37% | -259.40% +78.91% | -144.99% +81.60% | -79.84% -74.88% | |
Return on Equity | N/A N/A | N/A N/A | -207.98% +108.18% | -99.90% -73.77% | |
Revenue Growth | -148.40% +57.72% | -94.09% N/A | N/A N/A | N/A N/A | |
Current Ratio | 5.38 +192.84% | 1.84 +20.11% | 1.53 -66.87% | 4.61 -45.82% | |
Cash Ratio | 5.09 +238.57% | 1.50 +54.08% | 0.98 -77.99% | 4.44 -46.75% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow